Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study

Autor: Wilke T, Weisser B, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, Maywald U, Randerath O, Mueller S, Böhm M

Publikováno v: Integrated Blood Pressure Control, Vol Volume 15, Pp 11-21 (2022)

Thomas Wilke,1 Burkhard Weisser,2 Hans-Georg Predel,3 Roland Schmieder,4 Sven Wassmann,5 Anton Gillessen,6 Jörg Blettenberg,7 Ulf Maywald,8 Olaf Randerath,9 Sabrina Mueller,10 Michael Böhm11 1Institut für Pharmakoökonomie und Arzneimittellogistik

Externí odkaz: https://doaj.org/article/791ebf75be9f4f5ab7aa2ff3ec1938ba

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

2018 ESC/ESH guidelines for the diagnosis and treatment of arterial hypertension: The Task Force for the Diagnosis and Treatment of Arterial Hypertension of the European Society of Cardiology (ESC) and of the European Society of Hypertension (ESH)

Autor: Williams B., Mancia G., Spiering W., Rosei E. A., Azizi M., Burnier M., Clement D. L., Coca A., De Simone G., Dominiczak A., Kahan T., Mahfoud F., Redon J., Ruilope L., Zanchetti A., Kerins M., Kjeldsen S. E., Kreutz R., Laurent S., Lip G. Y. H., McManus R., Narkiewicz K., Ruschitzka F., Schmieder R. E., Shlyakhto E., Tsioufis C., Aboyans V., Desormais I., De Backer G., Heagerty A. M., Agewall S., Bochud M., Borghi C., Boutouyrie P., Brguljan J., Bueno H., Caiani E. G., Carlberg B., Chapman N., Cifkova R., Cleland J. G. F., Collet J. -P., Coman I. M., De Leeuw P. W., Delgado V., Dendale P., Diener H. -C., Dorobantu M., Fagard R., Farsang C., Ferrini M., Graham I. M., Grassi G., Haller H., Richard Hobbs F. D., Jelakovic B., Jennings C., Katus H. A., Kroon A. A., Leclercq C., Lovic D., Lurbe E., Manolis A. J., McDonagh T. A., Messerli F., Muiesan M. L., Nixdorff U., Olsen M. H., Parati G., Perk J., Piepoli M. F., Polonia J., Ponikowski P., Richter D. J., Rimoldi S. F., Roffi M., Sattar N., Seferovic P. M., Simpson I. A., Sousa-Uva M., Stanton A. V., Van De Borne P., Vardas P., Volpe M., Wassmann S., Windecker S., Zamorano J. L.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1299::9d35f8c04a399a451de8824a54f29376
http://hdl.handle.net/10281/280139

Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke

Autor: Sulzgruber, P, Wassmann, S, Semb, AG, Doehner, W, Widimsky, P, Gremmel, T, Kaski, JC, Savarese, G, Rosano, GMC, Borghi, C, Kjeldsen, K, Torp-Pedersen, C, Schmidt, TA, Lewis, BS, Drexel, H, Tamargo, J, Atar, D, Agewall, S, Niessner, A

Oral anticoagulation in patients presenting with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 (CHA2DS2-VASc of 2 in women) remains a challenging approach in clinical practice. Therapeutic decisions need to balance the individual ben

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::313865cf137215eece71884c09b710e5
https://openaccess.sgul.ac.uk/id/eprint/110889/1/pvz016.pdf